Share Price and Basic Stock Data
Last Updated: January 24, 2026, 3:33 pm
| PEG Ratio | 0.92 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
5Paisa Capital Ltd operates in the Finance & Investments sector, and as of the latest reporting, the company’s share price stood at ₹362, with a market capitalization of ₹1,132 Cr. The company reported a consistent upward trend in sales, with figures increasing from ₹79.55 Cr in September 2022 to ₹96.90 Cr in September 2023. This growth trajectory continued into December 2023, where sales reached ₹100.26 Cr. However, a notable decline was observed in the following quarters, with sales declining to ₹85.27 Cr in December 2024. For the fiscal year ending March 2025, total sales were recorded at ₹360 Cr, which, although lower than the ₹395 Cr reported for March 2024, still reflects a robust revenue base in comparison to previous fiscal years. The company’s ability to generate consistent sales growth is indicative of its operational capabilities within a competitive market environment.
Profitability and Efficiency Metrics
5Paisa Capital’s profitability showcases a positive trajectory, with a net profit of ₹47 Cr reported for the latest fiscal year, reflecting a net profit margin of 18.97% for March 2025. The operating profit margin (OPM) stood at 29.77%, highlighting efficient cost management alongside revenue growth. The company’s return on equity (ROE) was reported at 11.30%, while return on capital employed (ROCE) reached 18.60%, indicating effective utilization of shareholder funds and capital. The interest coverage ratio (ICR) of 5.35x demonstrates the company’s ability to meet its interest obligations comfortably. However, a decline in profit before tax was noted in March 2024 at ₹7.61 Cr, suggesting potential challenges in maintaining profitability in the face of rising expenses, which totaled ₹232 Cr for the fiscal year ending March 2025.
Balance Sheet Strength and Financial Ratios
The financial health of 5Paisa Capital is reflected in its balance sheet, with total assets amounting to ₹1,667 Cr and total liabilities of ₹1,667 Cr as of March 2025. The company reported reserves of ₹595 Cr, showcasing a strong equity base. Borrowings stood at ₹291 Cr, which translates to a debt-to-equity ratio of 0.36, indicating a conservative approach to leveraging. The current and quick ratios were both reported at 1.55, suggesting a strong liquidity position to cover short-term obligations. The price-to-book value (P/BV) ratio was recorded at 1.84x, which is within reasonable limits compared to industry norms, indicating that the stock is valued fairly relative to its book value. Overall, the balance sheet reflects a healthy financial structure, although the increase in borrowings may warrant monitoring for future financial flexibility.
Shareholding Pattern and Investor Confidence
5Paisa Capital’s shareholding structure shows a diverse ownership base, with promoters holding 32.74% of the shares, while foreign institutional investors (FIIs) accounted for 21.68%, and domestic institutional investors (DIIs) held a minimal 0.25%. The public holds a substantial 45.32%, demonstrating strong retail investor participation. The number of shareholders grew significantly from 25,005 in December 2022 to 55,170 by September 2025, indicating rising investor interest and confidence. However, the slight decline in promoter and FII holdings over the past year could raise concerns regarding long-term commitment from major stakeholders. The stable public ownership suggests a solid retail base, which can be a strength in terms of liquidity and market support in volatile conditions.
Outlook, Risks, and Final Insight
Looking ahead, 5Paisa Capital faces both opportunities and challenges. The company’s consistent revenue growth and strong profitability metrics position it favorably within the finance sector. However, potential risks include fluctuating market conditions that could impact revenue and profit margins, particularly given the observed decline in sales projections for the next fiscal year. The increasing borrowings may also pose a risk if not managed effectively amid changing interest rates. Additionally, competition from both traditional and fintech players in the investment space could pressure margins. In a favorable market environment, the company could leverage its operational efficiency to capture greater market share and enhance profitability. Conversely, adverse economic conditions could hinder growth and profitability, necessitating agile strategic responses to maintain its competitive edge.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.7 Cr. | 40.0 | 57.0/36.4 | 46.9 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,241 Cr. | 283 | 455/269 | 14.0 | 111 | 0.35 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 29.5 Cr. | 0.42 | 1.34/0.38 | 4.09 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 3.92 Cr. | 7.91 | 11.6/7.91 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 18.8 Cr. | 36.6 | 69.9/36.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,994.85 Cr | 1,277.46 | 67.41 | 3,844.56 | 0.38% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 79.55 | 83.76 | 90.59 | 84.55 | 96.90 | 100.26 | 112.86 | 102.24 | 100.79 | 85.27 | 71.27 | 77.69 | 77.17 |
| Expenses | 59.53 | 60.95 | 65.14 | 58.96 | 63.36 | 69.89 | 92.29 | 64.93 | 62.31 | 55.25 | 50.10 | 52.50 | 54.20 |
| Operating Profit | 20.02 | 22.81 | 25.45 | 25.59 | 33.54 | 30.37 | 20.57 | 37.31 | 38.48 | 30.02 | 21.17 | 25.19 | 22.97 |
| OPM % | 25.17% | 27.23% | 28.09% | 30.27% | 34.61% | 30.29% | 18.23% | 36.49% | 38.18% | 35.21% | 29.70% | 32.42% | 29.77% |
| Other Income | 0.67 | 0.04 | 0.86 | 0.03 | 0.04 | 0.07 | 0.02 | 0.04 | 0.05 | 0.04 | 0.14 | 0.08 | 0.13 |
| Interest | 4.53 | 5.99 | 4.63 | 3.84 | 6.47 | 7.99 | 10.26 | 7.16 | 6.03 | 5.41 | 5.20 | 7.28 | 7.97 |
| Depreciation | 2.09 | 2.17 | 2.48 | 2.31 | 2.24 | 2.27 | 2.72 | 3.30 | 3.19 | 3.10 | 2.64 | 2.50 | 2.38 |
| Profit before tax | 14.07 | 14.69 | 19.20 | 19.47 | 24.87 | 20.18 | 7.61 | 26.89 | 29.31 | 21.55 | 13.47 | 15.49 | 12.75 |
| Tax % | 23.67% | 25.05% | 25.00% | 25.37% | 23.44% | 25.22% | 24.18% | 25.29% | 25.28% | 24.92% | 25.24% | 25.50% | 25.57% |
| Net Profit | 10.75 | 11.02 | 14.41 | 14.54 | 19.04 | 15.09 | 5.78 | 20.09 | 21.90 | 16.18 | 10.07 | 11.55 | 9.48 |
| EPS in Rs | 3.51 | 3.60 | 4.70 | 4.75 | 6.19 | 4.84 | 1.85 | 6.44 | 7.01 | 5.18 | 3.22 | 3.70 | 3.03 |
Last Updated: January 2, 2026, 4:41 pm
Below is a detailed analysis of the quarterly data for 5Paisa Capital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 77.17 Cr.. The value appears to be declining and may need further review. It has decreased from 77.69 Cr. (Jun 2025) to 77.17 Cr., marking a decrease of 0.52 Cr..
- For Expenses, as of Sep 2025, the value is 54.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 52.50 Cr. (Jun 2025) to 54.20 Cr., marking an increase of 1.70 Cr..
- For Operating Profit, as of Sep 2025, the value is 22.97 Cr.. The value appears to be declining and may need further review. It has decreased from 25.19 Cr. (Jun 2025) to 22.97 Cr., marking a decrease of 2.22 Cr..
- For OPM %, as of Sep 2025, the value is 29.77%. The value appears to be declining and may need further review. It has decreased from 32.42% (Jun 2025) to 29.77%, marking a decrease of 2.65%.
- For Other Income, as of Sep 2025, the value is 0.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.08 Cr. (Jun 2025) to 0.13 Cr., marking an increase of 0.05 Cr..
- For Interest, as of Sep 2025, the value is 7.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.28 Cr. (Jun 2025) to 7.97 Cr., marking an increase of 0.69 Cr..
- For Depreciation, as of Sep 2025, the value is 2.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.50 Cr. (Jun 2025) to 2.38 Cr., marking a decrease of 0.12 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.75 Cr.. The value appears to be declining and may need further review. It has decreased from 15.49 Cr. (Jun 2025) to 12.75 Cr., marking a decrease of 2.74 Cr..
- For Tax %, as of Sep 2025, the value is 25.57%. The value appears to be increasing, which may not be favorable. It has increased from 25.50% (Jun 2025) to 25.57%, marking an increase of 0.07%.
- For Net Profit, as of Sep 2025, the value is 9.48 Cr.. The value appears to be declining and may need further review. It has decreased from 11.55 Cr. (Jun 2025) to 9.48 Cr., marking a decrease of 2.07 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.03. The value appears to be declining and may need further review. It has decreased from 3.70 (Jun 2025) to 3.03, marking a decrease of 0.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:49 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7 | 20 | 61 | 108 | 195 | 298 | 338 | 395 | 360 | 311 |
| Expenses | 22 | 51 | 78 | 99 | 150 | 251 | 252 | 284 | 232 | 212 |
| Operating Profit | -15 | -32 | -17 | 10 | 45 | 47 | 87 | 111 | 127 | 99 |
| OPM % | -199% | -161% | -28% | 9% | 23% | 16% | 26% | 28% | 35% | 32% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 1 | 1 | 7 | 15 | 21 | 23 | 21 | 29 | 24 | 26 |
| Depreciation | 0 | 1 | 1 | 4 | 5 | 5 | 9 | 10 | 12 | 11 |
| Profit before tax | -16 | -33 | -25 | -10 | 20 | 18 | 58 | 72 | 91 | 63 |
| Tax % | -29% | -24% | -25% | -18% | 26% | 26% | 25% | 25% | 25% | |
| Net Profit | -12 | -25 | -19 | -8 | 15 | 14 | 44 | 54 | 68 | 47 |
| EPS in Rs | -3.30 | -9.92 | -7.43 | -3.10 | 5.76 | 4.67 | 14.22 | 17.45 | 21.84 | 15.13 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -108.33% | 24.00% | 57.89% | 287.50% | -6.67% | 214.29% | 22.73% | 25.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | 132.33% | 33.89% | 229.61% | -294.17% | 220.95% | -191.56% | 3.20% |
5Paisa Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 6% |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 60% |
| 3 Years: | 71% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | 1% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 11% |
| Last Year: | 12% |
Last Updated: September 4, 2025, 9:50 pm
Balance Sheet
Last Updated: December 10, 2025, 2:17 am
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 25 | 26 | 29 | 31 | 31 | 31 | 31 |
| Reserves | 76 | 50 | 32 | 113 | 131 | 345 | 433 | 509 | 572 | 595 |
| Borrowings | 0 | 16 | 92 | 219 | 234 | 279 | 169 | 336 | 217 | 291 |
| Other Liabilities | 21 | 52 | 145 | 266 | 477 | 956 | 1,009 | 1,172 | 846 | 836 |
| Total Liabilities | 109 | 131 | 282 | 624 | 867 | 1,609 | 1,642 | 2,048 | 1,667 | 1,753 |
| Fixed Assets | 0 | 2 | 2 | 8 | 8 | 11 | 16 | 24 | 20 | 17 |
| CWIP | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 3 | 9 | 9 | 14 | 8 | 2 | 2 | 2 |
| Other Assets | 109 | 129 | 277 | 605 | 851 | 1,583 | 1,618 | 2,021 | 1,645 | 1,734 |
| Total Assets | 109 | 131 | 282 | 624 | 867 | 1,609 | 1,642 | 2,048 | 1,667 | 1,753 |
Below is a detailed analysis of the balance sheet data for 5Paisa Capital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
- For Reserves, as of Sep 2025, the value is 595.00 Cr.. The value appears strong and on an upward trend. It has increased from 572.00 Cr. (Mar 2025) to 595.00 Cr., marking an increase of 23.00 Cr..
- For Borrowings, as of Sep 2025, the value is 291.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 217.00 Cr. (Mar 2025) to 291.00 Cr., marking an increase of 74.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 836.00 Cr.. The value appears to be improving (decreasing). It has decreased from 846.00 Cr. (Mar 2025) to 836.00 Cr., marking a decrease of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,753.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,667.00 Cr. (Mar 2025) to 1,753.00 Cr., marking an increase of 86.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,734.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,645.00 Cr. (Mar 2025) to 1,734.00 Cr., marking an increase of 89.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,753.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,667.00 Cr. (Mar 2025) to 1,753.00 Cr., marking an increase of 86.00 Cr..
Notably, the Reserves (595.00 Cr.) exceed the Borrowings (291.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -15.00 | -48.00 | -109.00 | -209.00 | -189.00 | -232.00 | -82.00 | -225.00 | -90.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 10 | 12 | 0 | -0 | 0 | 0 | 0 | 0 |
| Inventory Days | |||||||||
| Days Payable | |||||||||
| Cash Conversion Cycle | 20 | 10 | 12 | 0 | -0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -210 | -320 | -555 | -477 | -577 | -1,026 | -941 | -899 | -785 |
| ROCE % | -39% | -17% | 2% | 11% | 8% | 12% | 13% | 14% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Banking & Financial Services Fund | 66,069 | 0.71 | 3.98 | 66,069 | 2025-04-22 17:25:44 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 21.86 | 17.65 | 14.42 | 4.72 | 5.76 |
| Diluted EPS (Rs.) | 21.79 | 16.67 | 14.33 | 4.68 | 5.73 |
| Cash EPS (Rs.) | 25.76 | 20.51 | 17.09 | 6.38 | 7.56 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 193.25 | 173.09 | 151.21 | 127.13 | 61.17 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 193.25 | 173.09 | 151.21 | 127.13 | 61.17 |
| Revenue From Operations / Share (Rs.) | 115.11 | 126.50 | 110.28 | 100.95 | 75.61 |
| PBDIT / Share (Rs.) | 40.74 | 35.34 | 28.57 | 15.43 | 17.42 |
| PBIT / Share (Rs.) | 36.82 | 32.28 | 25.70 | 13.72 | 15.62 |
| PBT / Share (Rs.) | 29.20 | 23.12 | 18.96 | 6.29 | 7.80 |
| Net Profit / Share (Rs.) | 21.84 | 17.45 | 14.22 | 4.67 | 5.76 |
| NP After MI And SOA / Share (Rs.) | 21.84 | 17.45 | 14.22 | 4.67 | 5.76 |
| PBDIT Margin (%) | 35.38 | 27.93 | 25.90 | 15.28 | 23.04 |
| PBIT Margin (%) | 31.98 | 25.51 | 23.30 | 13.59 | 20.65 |
| PBT Margin (%) | 25.36 | 18.27 | 17.19 | 6.23 | 10.31 |
| Net Profit Margin (%) | 18.97 | 13.79 | 12.89 | 4.62 | 7.61 |
| NP After MI And SOA Margin (%) | 18.97 | 13.79 | 12.89 | 4.62 | 7.61 |
| Return on Networth / Equity (%) | 11.30 | 10.08 | 9.40 | 3.67 | 9.41 |
| Return on Capital Employeed (%) | 18.60 | 18.12 | 16.60 | 10.56 | 25.05 |
| Return On Assets (%) | 4.09 | 2.65 | 2.65 | 0.85 | 1.69 |
| Total Debt / Equity (X) | 0.36 | 0.62 | 0.36 | 0.74 | 1.50 |
| Asset Turnover Ratio (%) | 0.19 | 0.21 | 0.20 | 0.23 | 0.25 |
| Current Ratio (X) | 1.55 | 1.35 | 1.38 | 1.28 | 1.18 |
| Quick Ratio (X) | 1.55 | 1.35 | 1.38 | 1.28 | 1.18 |
| Interest Coverage Ratio (X) | 5.35 | 3.86 | 4.24 | 2.08 | 2.23 |
| Interest Coverage Ratio (Post Tax) (X) | 3.87 | 2.91 | 3.11 | 1.63 | 1.74 |
| Enterprise Value (Cr.) | -8.75 | 271.77 | -265.37 | 93.47 | 346.91 |
| EV / Net Operating Revenue (X) | -0.02 | 0.68 | -0.78 | 0.31 | 1.80 |
| EV / EBITDA (X) | -0.06 | 2.47 | -3.03 | 2.06 | 7.80 |
| MarketCap / Net Operating Revenue (X) | 3.09 | 3.99 | 2.56 | 3.42 | 3.30 |
| Price / BV (X) | 1.84 | 2.91 | 1.87 | 2.71 | 4.08 |
| Price / Net Operating Revenue (X) | 3.09 | 3.99 | 2.56 | 3.42 | 3.30 |
| EarningsYield | 0.06 | 0.03 | 0.05 | 0.01 | 0.02 |
After reviewing the key financial ratios for 5Paisa Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 21.86. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 21.86, marking an increase of 4.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 21.79. This value is within the healthy range. It has increased from 16.67 (Mar 24) to 21.79, marking an increase of 5.12.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.76. This value is within the healthy range. It has increased from 20.51 (Mar 24) to 25.76, marking an increase of 5.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 193.25. It has increased from 173.09 (Mar 24) to 193.25, marking an increase of 20.16.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 193.25. It has increased from 173.09 (Mar 24) to 193.25, marking an increase of 20.16.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 115.11. It has decreased from 126.50 (Mar 24) to 115.11, marking a decrease of 11.39.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 40.74. This value is within the healthy range. It has increased from 35.34 (Mar 24) to 40.74, marking an increase of 5.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 36.82. This value is within the healthy range. It has increased from 32.28 (Mar 24) to 36.82, marking an increase of 4.54.
- For PBT / Share (Rs.), as of Mar 25, the value is 29.20. This value is within the healthy range. It has increased from 23.12 (Mar 24) to 29.20, marking an increase of 6.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 21.84. This value is within the healthy range. It has increased from 17.45 (Mar 24) to 21.84, marking an increase of 4.39.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 21.84. This value is within the healthy range. It has increased from 17.45 (Mar 24) to 21.84, marking an increase of 4.39.
- For PBDIT Margin (%), as of Mar 25, the value is 35.38. This value is within the healthy range. It has increased from 27.93 (Mar 24) to 35.38, marking an increase of 7.45.
- For PBIT Margin (%), as of Mar 25, the value is 31.98. This value exceeds the healthy maximum of 20. It has increased from 25.51 (Mar 24) to 31.98, marking an increase of 6.47.
- For PBT Margin (%), as of Mar 25, the value is 25.36. This value is within the healthy range. It has increased from 18.27 (Mar 24) to 25.36, marking an increase of 7.09.
- For Net Profit Margin (%), as of Mar 25, the value is 18.97. This value exceeds the healthy maximum of 10. It has increased from 13.79 (Mar 24) to 18.97, marking an increase of 5.18.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.97. This value is within the healthy range. It has increased from 13.79 (Mar 24) to 18.97, marking an increase of 5.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.30. This value is below the healthy minimum of 15. It has increased from 10.08 (Mar 24) to 11.30, marking an increase of 1.22.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.60. This value is within the healthy range. It has increased from 18.12 (Mar 24) to 18.60, marking an increase of 0.48.
- For Return On Assets (%), as of Mar 25, the value is 4.09. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.09, marking an increase of 1.44.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.36, marking a decrease of 0.26.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.19. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 1.35 (Mar 24) to 1.55, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 1.35 (Mar 24) to 1.55, marking an increase of 0.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.35. This value is within the healthy range. It has increased from 3.86 (Mar 24) to 5.35, marking an increase of 1.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.87. This value is within the healthy range. It has increased from 2.91 (Mar 24) to 3.87, marking an increase of 0.96.
- For Enterprise Value (Cr.), as of Mar 25, the value is -8.75. It has decreased from 271.77 (Mar 24) to -8.75, marking a decrease of 280.52.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is -0.02. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 24) to -0.02, marking a decrease of 0.70.
- For EV / EBITDA (X), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has decreased from 2.47 (Mar 24) to -0.06, marking a decrease of 2.53.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.09. This value exceeds the healthy maximum of 3. It has decreased from 3.99 (Mar 24) to 3.09, marking a decrease of 0.90.
- For Price / BV (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has decreased from 2.91 (Mar 24) to 1.84, marking a decrease of 1.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.09. This value exceeds the healthy maximum of 3. It has decreased from 3.99 (Mar 24) to 3.09, marking a decrease of 0.90.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 5Paisa Capital Ltd:
- Net Profit Margin: 18.97%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.6% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.3% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.87
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.55
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.3 (Industry average Stock P/E: 67.41)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.36
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.97%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | IIFL House, Sun Infotech Park, Thane Maharashtra 400604 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Archana Niranjan Hingorani | Chairperson & Independent Director |
| Mr. Gaurav Seth | Managing Director & CEO |
| Mr. Gourav Munjal | WholeTime Director & CFO |
| Mr. Ameya Agnihotri | Whole Time Director |
| Mr. Milin Mehta | Independent Director |
| Mr. Ravindra Garikipati | Independent Director |
| Ms. Nirali Sanghi | Independent Director |
| Dr. Sarat Kumar Malik | Independent Director |
FAQ
What is the intrinsic value of 5Paisa Capital Ltd?
5Paisa Capital Ltd's intrinsic value (as of 24 January 2026) is ₹597.01 which is 77.15% higher the current market price of ₹337.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,053 Cr. market cap, FY2025-2026 high/low of ₹434/288, reserves of ₹595 Cr, and liabilities of ₹1,753 Cr.
What is the Market Cap of 5Paisa Capital Ltd?
The Market Cap of 5Paisa Capital Ltd is 1,053 Cr..
What is the current Stock Price of 5Paisa Capital Ltd as on 24 January 2026?
The current stock price of 5Paisa Capital Ltd as on 24 January 2026 is ₹337.
What is the High / Low of 5Paisa Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of 5Paisa Capital Ltd stocks is ₹434/288.
What is the Stock P/E of 5Paisa Capital Ltd?
The Stock P/E of 5Paisa Capital Ltd is 24.3.
What is the Book Value of 5Paisa Capital Ltd?
The Book Value of 5Paisa Capital Ltd is 200.
What is the Dividend Yield of 5Paisa Capital Ltd?
The Dividend Yield of 5Paisa Capital Ltd is 0.00 %.
What is the ROCE of 5Paisa Capital Ltd?
The ROCE of 5Paisa Capital Ltd is 13.6 %.
What is the ROE of 5Paisa Capital Ltd?
The ROE of 5Paisa Capital Ltd is 11.9 %.
What is the Face Value of 5Paisa Capital Ltd?
The Face Value of 5Paisa Capital Ltd is 10.0.